| 20th Nov 2020 7:00 am |
RNS |
Imfinzi new dosing approved in the US |
| 10th Nov 2020 7:00 am |
RNS |
Tezepelumab Phase III trial met primary endpoint |
| 9th Nov 2020 7:00 am |
RNS |
Calquence approved in the EU for CLL |
| 6th Nov 2020 7:00 am |
RNS |
Brilinta approved in the US in stroke |
| 5th Nov 2020 7:15 am |
RNS |
Lynparza approved in the EU for wider ovarian use |
| 5th Nov 2020 7:10 am |
RNS |
Lynparza approved in the EU for prostate cancer |
| 5th Nov 2020 7:05 am |
RNS |
Forxiga approved in the EU for heart failure |
| 5th Nov 2020 7:00 am |
RNS |
AZN: Year-to-date and Q3 2020 results |
| 2nd Nov 2020 3:00 pm |
RNS |
Total Voting Rights |
| 30th Oct 2020 7:00 am |
RNS |
Atacand to be divested in more than 70 countries |
| 29th Oct 2020 7:00 am |
RNS |
Directorate Change |
| 28th Oct 2020 7:03 am |
RNS |
Enhertu US Priority Review in gastric cancer |
| 28th Oct 2020 7:00 am |
RNS |
Forxiga CV outcomes benefit approved in China |
| 20th Oct 2020 7:00 am |
RNS |
Tagrisso adjuvant lung cancer US Priority Review |
| 19th Oct 2020 7:00 am |
RNS |
Forxiga HF receives positive CHMP opinion |
| 19th Oct 2020 7:00 am |
RNS |
Trixeo Aerosphere receives positive CHMP opinion |
| 12th Oct 2020 7:00 am |
RNS |
COVID-19 antibodies advance and get US funding |
| 2nd Oct 2020 11:19 am |
RNS |
Holding(s) in Company |
| 2nd Oct 2020 7:00 am |
RNS |
Farxiga granted US BTD in chronic kidney disease |
| 1st Oct 2020 3:00 pm |
RNS |
Total Voting Rights |
| 25th Sep 2020 7:00 am |
RNS |
Directorate Change |
| 21st Sep 2020 7:05 am |
RNS |
Lynparza EU recommendation in prostate cancer |
| 21st Sep 2020 7:00 am |
RNS |
Lynparza EU recommendation in ovarian cancer |
| 21st Sep 2020 7:00 am |
RNS |
Tagrisso reduced early lung cancer brain recurrenc |
| 10th Sep 2020 7:01 am |
RNS |
AstraZeneca to list all US securities on Nasdaq |
| 10th Sep 2020 7:00 am |
RNS |
Fasenra PhIII OSTRO trial met co-primary endpoints |
| 1st Sep 2020 3:00 pm |
RNS |
Total Voting Rights |
| 1st Sep 2020 7:00 am |
RNS |
Imfinzi approved in EU for small cell lung cancer |
| 1st Sep 2020 7:00 am |
RNS |
Farxiga reduces CKD progression and risk of death |
| 25th Aug 2020 7:00 am |
RNS |
Ph I trial begins for COVID-19 monoclonal antibody |
| 21st Aug 2020 7:00 am |
RNS |
Imfinzi approved in Japan for SCLC |
| 18th Aug 2020 7:00 am |
RNS |
Imfinzi US Priority Review; four-week, fixed dose |
| 4th Aug 2020 7:00 am |
RNS |
AstraZeneca prices a $3bn bond issue |
| 3rd Aug 2020 3:00 pm |
RNS |
Total Voting Rights |
| 30th Jul 2020 7:25 am |
RNS |
Tagrisso US BTD for EGFRm adjuvant lung cancer |
| 30th Jul 2020 7:18 am |
RNS |
AZN: H1 2020 results |
| 29th Jul 2020 7:00 am |
RNS |
Board Committee Changes |
| 28th Jul 2020 7:00 am |
RNS |
Farxiga DAPA-CKD trial met all endpoints |
| 27th Jul 2020 7:10 am |
RNS |
Calquence receives positive CHMP opinion for CLL |
| 27th Jul 2020 7:05 am |
RNS |
Imfinzi recommended for EU approval in SCLC |
